UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

EADB: an estrogenic activity database for assessing potential endocrine activity

Toxicological sciences, 2013-10, Vol.135 (2), p.277-291

2013

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Cardiac Delayed Rectifier K+ Current by Overexpression of the Long-QT Syndrome HERG G628S Mutation in Transgenic Mice

Circulation research, 1998-09, Vol.83 (6), p.668-678

1998

Link zum Volltext

Verfügbarkeit prüfen

Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate : implications for gene-specific therapy

Circulation (New York, N.Y.), 1995-12, Vol.92 (12), p.3381-3386

1995

Link zum Volltext

Verfügbarkeit prüfen

Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery disease

Current opinion in investigational drugs (London, England : 2000), 2009-03, Vol.10 (3), p.239

Colatsky, Thomas J

2009

Link zum Volltext

Verfügbarkeit prüfen

'Impedance matching' of data sets in biomarker research

Current opinion in investigational drugs (London, England : 2000), 2010-03, Vol.11 (3), p.262

Colatsky, Thomas J

2010

Link zum Volltext

Verfügbarkeit prüfen

A return to rational drug discovery: computer-based models of cells, organs and systems in drug target identification

Emerging therapeutic targets, 2000-02, Vol.4 (1), p.39-49

2000

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat

The Journal of pharmacology and experimental therapeutics, 1999-06, Vol.289 (3), p.1410

1999

Link zum Volltext

Verfügbarkeit prüfen

What happens when cardiac Na channels lose their function? 1 - Numerical studies of the vulnerable period in tissue expressing mutant channels

Cardiovascular research, 2003, Vol.57 (1), p.82-91

2003

Link zum Volltext

Verfügbarkeit prüfen

Emerging Technologies and their Role in Regulatory Review

Drug Discovery Toxicology, 2016, p.1-11

2016

Link zum Volltext

Verfügbarkeit prüfen

Metabolic profiling and biomarker discovery

Current opinion in investigational drugs (London, England : 2000), 2003-03, Vol.4 (3), p.262

2003

Link zum Volltext

Verfügbarkeit prüfen

Ion Channels: Too Complex for Rational Drug Design?

Neuron, 1996-05, Vol.16 (5), p.913-919

1996

Link zum Volltext

Verfügbarkeit prüfen

Antiarrhythmic drug binding sites in cardiac K+ channels

Circulation research, 1996-06, Vol.78 (6), p.1115-1116

Colatsky, T J

1996

Link zum Volltext

Verfügbarkeit prüfen

Differential block of cardiac delayed rectifier current by class Ic antiarrhythmic drugs: evidence for open channel block and unblock

Cardiovascular research, 1992-11, Vol.26 (11), p.1121-1130

1992

Link zum Volltext

Verfügbarkeit prüfen

Editorial overview. Biomarker-enabled drug discovery: bridging the gap between disease and target knowledge

Current opinion in investigational drugs (London, England : 2000), 2004-03, Vol.5 (3), p.269

2004

Link zum Volltext

Verfügbarkeit prüfen

Cellular electrophysiology of WAY-123,398, a new class III antiarrhythmic agent: specificity of IK block and lack of reverse use dependence in cat ventricular myocytes

Cardiovascular research, 1993-09, Vol.27 (9), p.1580-1591

1993

Link zum Volltext

Verfügbarkeit prüfen

Effects of WAY-123,398, a New Class III Antiarrhythmic Agent, on Cardiac Refractoriness and Ventricular Fibrillation Threshold in Anesthetized Dogs: A Comparison with UK-68798, E-4031, and dl-Sotalol

Journal of cardiovascular pharmacology, 1992-12, Vol.20 (6), p.913-922

1992

Link zum Volltext

Verfügbarkeit prüfen

Commentaries on the Cardiovascular Controversy by W Spinelli and T J Colatsky

Cardiovascular research, 1994-06, Vol.28 (6), p.926-928

1994

Link zum Volltext

Verfügbarkeit prüfen

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

Circulation (New York, N.Y.), 1990-12, Vol.82 (6), p.2235-2242

1990

Link zum Volltext

Verfügbarkeit prüfen

Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes

Circulation (New York, N.Y.), 1990-07, Vol.82 (1), p.289-293

1990

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Action of Lidocaine and Quinidine on Action Potential Duration in Rabbit Cardiac Purkinje Fibers: An Effect on Steady State Sodium Currents?

Circulation research, 1982-01, Vol.50 (1), p.17-27

COLATSKY, THOMAS J

1982

Link zum Volltext

Verfügbarkeit prüfen

Potassium channel blockers as antiarrhythmic drugs

Drug development research, 1994-11, Vol.33 (3), p.235-249

1994

Link zum Volltext

Verfügbarkeit prüfen

Controlling Cardiac Arrhythmias: New Drugs in Development and Insights From Molecular Biology

Journal of cardiovascular pharmacology and therapeutics, 1998-12, Vol.3 (4), p.337-341

Colatsky, Thomas J.

1998

Link zum Volltext

Verfügbarkeit prüfen

The Sicilian Gambit and antiarrhythmic drug development

Cardiovascular research, 1992-06, Vol.26 (6), p.562-565

COLATSKY, T. J

1992

Link zum Volltext

Verfügbarkeit prüfen

Antiarrhythmic Drug Binding Sites in Cardiac K sup plus Channels

Circulation research, 1996-06, Vol.78 (6), p.1115-1116

Colatsky, Thomas J

1996

Link zum Volltext

Verfügbarkeit prüfen

Tetrodotoxin block of sodium channels in rabbit Purkinje fibers. Interactions between toxin binding and channel gating

The Journal of general physiology, 1981-10, Vol.78 (4), p.383-411

1981

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(39)
Buchkapitel
(1)

Sprache

Englisch
(40)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Animals
(20)
Humans
(16)
Cardiovascular System & Cardiology
(14)
Pharmacology & Pharmacy
(13)
Biological And Medical Sciences
(12)
Cardiac & Cardiovascular Systems
(12)
Medical Sciences
(12)
Male
(10)
Peripheral Vascular Disease
(9)
Anti-Arrhythmia Agents - Pharmacology
(8)
Pharmacology. Drug Treatments
(8)
Dogs
(7)
Hematology
(7)
Potassium Channels - Drug Effects
(7)
Cardiovascular System
(6)
Female
(6)
Antiarythmic Agents
(5)
In Vitro Techniques
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EADB: an estrogenic activity database for assessing potential endocrine activity

Inhibition of Cardiac Delayed Rectifier K+ Current by Overexpression of the Long-QT Syndrome HERG G628S Mutation in Transgenic Mice

Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate : implications for gene-specific therapy

Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery disease

'Impedance matching' of data sets in biomarker research

A return to rational drug discovery: computer-based models of cells, organs and systems in drug target identification

Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat

What happens when cardiac Na channels lose their function? 1 - Numerical studies of the vulnerable period in tissue expressing mutant channels

Emerging Technologies and their Role in Regulatory Review

Metabolic profiling and biomarker discovery

Ion Channels: Too Complex for Rational Drug Design?

Antiarrhythmic drug binding sites in cardiac K+ channels

Differential block of cardiac delayed rectifier current by class Ic antiarrhythmic drugs: evidence for open channel block and unblock

Editorial overview. Biomarker-enabled drug discovery: bridging the gap between disease and target knowledge

Cellular electrophysiology of WAY-123,398, a new class III antiarrhythmic agent: specificity of IK block and lack of reverse use dependence in cat ventricular myocytes

Effects of WAY-123,398, a New Class III Antiarrhythmic Agent, on Cardiac Refractoriness and Ventricular Fibrillation Threshold in Anesthetized Dogs: A Comparison with UK-68798, E-4031, and dl-Sotalol

Commentaries on the Cardiovascular Controversy by W Spinelli and T J Colatsky

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes

Mechanisms of Action of Lidocaine and Quinidine on Action Potential Duration in Rabbit Cardiac Purkinje Fibers: An Effect on Steady State Sodium Currents?

Potassium channel blockers as antiarrhythmic drugs

Controlling Cardiac Arrhythmias: New Drugs in Development and Insights From Molecular Biology

The Sicilian Gambit and antiarrhythmic drug development

Antiarrhythmic Drug Binding Sites in Cardiac K sup plus Channels

Tetrodotoxin block of sodium channels in rabbit Purkinje fibers. Interactions between toxin binding and channel gating

Suchergebnisse filtern